Source link : https://newshealth.biz/health-news/early-egfr-dip-likely-doesnt-hinder-sglt2-inhibitors-kidney-benefits/
(MedPage Today) — The SGLT2 inhibitor empagliflozin (Jardiance) reduced the risk of creatinine increases and acute kidney injury (AKI) even in those with an early dip in estimated glomerular filtration rate (eGFR), according to a meta-analysis… Source link : https://www.medpagetoday.com/meetingcoverage/era/115988 Author : Publish date : 2025-06-10 13:25:00 Copyright for syndicated content belongs to the linked […]
The post Early eGFR Dip Likely Doesn’t Hinder SGLT2 Inhibitor’s Kidney Benefits first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-10 13:25:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8